Future OutlookThe company’s 2H25 outlook remains positive with a backlog of $1.4M, approximately $2.0M of contracts under negotiations, and $15.0M of open opportunities for Custom Engineered System (CES), Hybrid Solutions, and SteraMist (SIS) offerings.
International ExpansionInternational expansion continues with nearly 20% of 2Q25 revenues coming from outside the U.S., and long-term international partners in Germany, the Netherlands, and Italy have developed strong pipelines pending the final EU and UK registration approvals.
Product DemandThe company has announced several developments across its product portfolio demonstrating evidence of demand for the company’s products and services, including a $450K contract to install a SteraMist iHP Custom Engineered System (CES) at a university in Rhode Island.